Category Archives: Press Release

HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors

Acquisition will Accelerate Global Expansion of Company’s Breakthrough Edison® Histotripsy Platform and Non-Invasive Tumor Therapy   MINNEAPOLIS – August 7, 2025 – HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced a management-led majority stake acquisition by a syndicate of globally recognized private and public investors, including K5 Global, […]

HistoSonics Raises $102 Million for Liver Cancer Treatment

A noninvasive technology that uses sound waves to destroy tumors gets a tailwind from VC interest in late-stage medtechs By Brian Gormley HistoSonics’ technology, which received FDA clearance in October 2023, destroys liver tumors using high-intensity sound waves. Photo: HistoSonics With investor interest in later-stage medical-technology companies accelerating, venture capitalists have supplied $102 million in […]

FDA AWARDS HISTOSONICS CLEARANCE OF ITS FIRST-OF-A-KIND EDISON® HISTOTRIPSY SYSTEM

HistoSonics®, (www.histosonics.com), the manufacturer of the Edison® System and novel histotripsy therapy platforms, announced today the marketing authorization of its “Breakthrough” platform via the U.S. Food and Drug Administration’s (FDA) De Novo Classification Request process, a rigorous pre-market review pathway for medical devices with no existing predicate. Marketing authorization makes Edison the first and only […]

HistoSonics Announces First Ever KidneyTumor Treatment Using Histotripsy

Leeds Teaching Hospitals NHS Trust, (UK) Performs Non-Invasive Histotripsy in Patient with Primary Solid Renal Tumor MINNEAPOLIS, March 30, 2023 /PRNewswire/ — HistoSonics, (www.histosonics.com), the developer of a non-invasive platform and novel sonic beam therapy called histotripsy, announced today the first kidney patient has been treated using the Company’s histotripsy platform. The procedure was performed […]

ShiftKey Makes a Strategic Investment in Workforce Management Platform OnShift

Dallas – June 22, 2022, – ShiftKey, the largest platform for connecting independent licensed healthcare professionals with open shifts at healthcare facilities in the U.S. announced today that it has completed a strategic investment in Cleveland-based OnShift, the leading provider of workforce management technology for post-acute and long-term care facilities. “Since our founding, our goal has […]

HistoSonics Hits Pivotal Clinical Trial Milestone In #HOPE4LIVER Studies

MINNEAPOLIS, May 31, 2022 /PRNewswire/ — HistoSonics, (www.histosonics.com), the developer and manufacturer of a non-invasive platform and novel sonic beam therapy called histotripsy, announced today the fulfillment of patient enrollment required for regulatory submission of their Edison™ system to the US Food and Drug Administration (FDA). The company plans to use safety and efficacy data from combined parallel […]

OnShift Announces Groundbreaking Initiative to Address Workforce Shortage in Senior Care

The company will connect AI-driven technology with caregiver marketplaces for fast, intelligent and cost-effective shift assignments Cleveland, OH, November 10, 2021 — OnShift®, a leader in human capital management software for post-acute care and senior living, today announced the launch of a new initiative that will provide integrated access to third-party caregiver marketplaces from within OnShift’s award-winning […]

Histotripsy is one such therapy that has the promise of changing cancer care

See Article: https://evtoday.com/articles/2021-oct/interventional-oncology-fast-forward-to-the-future?c4src=current:feed Histotripsy is one such therapy that has the promise of changing cancer care. It is a completely noninvasive approach akin to radiation oncology without the toxicity due to radiation and to high-intensity focused ultrasound without the problems inherent in thermal deposition in tissue with existing ablative therapies.6 The cellular destruction caused by histotripsy […]

HistoSonics Receives FDA “Breakthrough Device Designation” for Novel Sonic Beam Therapy

HistoSonics Receives FDA “Breakthrough Device Designation” for Novel Sonic Beam Therapy Breakthrough status for new histotripsy targeted liver therapy will help provide timely access to non-invasive liver treatment MINNEAPOLIS, Oct. 18, 2021 /PRNewswire/ — HistoSonics, (www.histosonics.com), the developer and manufacturer of a non-invasive platform and novel sonic beam therapy called histotripsy, announced today that the U.S. Food and […]

InComm Payments partners with Intelligent Clearing Network to provide cloud-based solution aimed at preventing paper coupon fraud

OLS Payments, an InComm Payments company, today announced a new partnership with Intelligent Clearing Network (ICN), a software-as-a-service coupon clearing company, to provide retailers with a solution addressing multiple issues related to paper coupon fraud, processing, and clearing.